<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629315</url>
  </required_header>
  <id_info>
    <org_study_id>NP458/13</org_study_id>
    <nct_id>NCT02629315</nct_id>
  </id_info>
  <brief_title>Carnoy`s Solution Versus Formalin in Rectal and Gastric Cancer Specimens Following: a Randomized Trial</brief_title>
  <official_title>Lymph Node Yield After Specimen Fixation With Carnoy`s Solution and 10% Neutral Buffered Formaldehyde in Patients With Colorectal Cancer or Gastric Adenocarcinoma Specimens: a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto do Cancer do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto do Cancer do Estado de São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the number of lymph nodes dissected in specimens following fixation with
      10% neutral buffered formaldehyde or Carnoy's solution. Specimens were randomized for
      fixation in each solution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carnoy's solution is a tissue fixative that has alcohol allowing for fat clearing along with
      tissue fixation. Specimens were randomized after the surgical procedure. The perivisceral fat
      was removed from the stomach and the lymph node stations disected and then fixed in formalin
      or carnoy`s solution for 24-48h. After dissection the residual fat from the formalin group
      was re-fixed in carnoy and re-disected.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2012</start_date>
  <completion_date type="Actual">February 10, 2014</completion_date>
  <primary_completion_date type="Actual">February 10, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>Randomization occurred after surgery, the surgeon was blind during the procedure</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Lymph node yield</measure>
    <time_frame>10 days - accessed with the pathological report for each specimen</time_frame>
    <description>Primary outcome will be the total number of lymph nodes dissected in each specimen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dissection duration</measure>
    <time_frame>10 days - accessed with the pathological report for each specimen</time_frame>
    <description>Secondary outcome will be measured in minutes, counting from the start to the end of the dissection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Gastric Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>10% neutral buffered formaldehyde</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Specimens will be fixed for 24-48hours in 10% neutral buffered formaldehyde and then dissected for lymph nodes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carnoy's solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Specimens will be fixed for 24-48hours in Carno'ys solution and then dissected for lymph nodes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Carnoy's solution</intervention_name>
    <arm_group_label>Carnoy's solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>10% neutral buffered formaldehyde</intervention_name>
    <arm_group_label>10% neutral buffered formaldehyde</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria - Rectal Cancer:

          -  Long course neoadjuvant chemoradiation

          -  Low anterior resection with total mesorectal excision

        Inclusion Criteria - Colon Cancer:

        - Rectosigmoidectomy

        Inclusion Criteria - Gastric Cancer:

          -  Gastric adenocarcinoma

          -  Subtotal gastrectomy

          -  D2 lymphadenectomy

        Exclusion Criteria - Rectal Cancer:

          -  Previous surgery

          -  Incomplete neoadjuvant chemoradiation

          -  Refuse to sign the informed consent

          -  T4b and/or Multivisceral resection

        Exclusion Criteria - Colon Cancer:

          -  Previous surgery

          -  Neoadjuvant chemoradiation

          -  Refuse to sign the informed consent

          -  T4b and/or Multivisceral resection

        Exclusion Criteria - Gastric Cancer:

          -  Distant metastasis

          -  Previous upper abdomen radiotherapy

          -  Previous surgery over stomach or omentum

          -  Refuse to sign the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Dias AR, Pereira MA, Mello ES, Zilberstein B, Cecconello I, Ribeiro Junior U. Carnoy's solution increases the number of examined lymph nodes following gastrectomy for adenocarcinoma: a randomized trial. Gastric Cancer. 2016 Jan;19(1):136-42. doi: 10.1007/s10120-014-0443-2. Epub 2014 Nov 20.</citation>
    <PMID>25410474</PMID>
  </reference>
  <reference>
    <citation>Pereira MA, Dias AR, Faraj SF, Cirqueira Cdos S, Tomitao MT, Nahas SC, Ribeiro U Jr, de Mello ES. Carnoy's solution is an adequate tissue fixative for routine surgical pathology, preserving cell morphology and molecular integrity. Histopathology. 2015 Feb;66(3):388-97. doi: 10.1111/his.12532. Epub 2014 Nov 10.</citation>
    <PMID>25307771</PMID>
  </reference>
  <reference>
    <citation>Luz DA, Ribeiro U Jr, Chassot C, Collet E Silva Fde S, Cecconello I, Corbett CE. Carnoy's solution enhances lymph node detection: an anatomical dissection study in cadavers. Histopathology. 2008 Dec;53(6):740-2. doi: 10.1111/j.1365-2559.2008.03148.x.</citation>
    <PMID>19076686</PMID>
  </reference>
  <reference>
    <citation>Duldulao M, Booth C, Denham L, Choi A, Friedman G, Kazanjian K. Alcohol fat clearing increases lymph node yield after surgery for colorectal cancer. Am Surg. 2014 Oct;80(10):1054-8.</citation>
    <PMID>25264659</PMID>
  </reference>
  <reference>
    <citation>Scabini S, Montecucco F, Nencioni A, Zoppoli G, Sartini M, Rimini E, Massobrio A, De Marini L, Poggi A, Boaretto R, Romairone E, Ballestrero A, Ferrando V. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. World J Surg Oncol. 2013 Nov 18;11:292. doi: 10.1186/1477-7819-11-292.</citation>
    <PMID>24246069</PMID>
  </reference>
  <reference>
    <citation>Dias AR, Pereira MA, de Mello ES, Nahas SC, Cecconello I, Ribeiro U Jr. Lymph Node Yield After Neoadjuvant Chemoradiotherapy in Rectal Cancer Specimens: A Randomized Trial Comparing Two Fixatives. Dis Colon Rectum. 2018 Aug;61(8):888-896. doi: 10.1097/DCR.0000000000001097.</citation>
    <PMID>29944580</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2015</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Formaldehyde</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

